on NOVACYT (EPA:ALNOV)
Novacyt's monthly performance: Liquidity contract review
Novacyt, a company active in molecular diagnostics, presents its monthly report on its liquidity contract with Invest Securities. In May 2026, the company purchased 155,207 shares at prices ranging from €0.31 to €0.77. It sold 225,895 shares at prices ranging from €0.32 to €0.88. As of May 31, Novacyt held 74,373 treasury shares.
The total number of ordinary shares, 72,588,088, provides a basis for shareholders wishing to declare or revise their shareholdings in accordance with French regulations. The company does not comply with UK transparency rules.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all NOVACYT news